Nahdi Medical Company
TADAWUL:4164.SR
132.8 (SAR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 8,713.7 | 8,616.188 | 8,066.215 | 8,642.207 | 7,824.674 | 7,350.003 | 7,056.423 |
| Cost of Revenue
| 5,191.5 | 5,095.296 | 4,761.534 | 5,762.381 | 5,856.287 | 5,419.182 | 5,048.866 |
| Gross Profit
| 3,522.2 | 3,520.892 | 3,304.681 | 2,879.826 | 1,968.387 | 1,930.821 | 2,007.558 |
| Gross Profit Ratio
| 0.404 | 0.409 | 0.41 | 0.333 | 0.252 | 0.263 | 0.285 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 67.597 | 68.825 | 52.236 | 310.64 | 310.2 | 260.731 | 243.14 |
| Selling & Marketing Expenses
| 394.63 | 352.601 | 335.648 | 1,958.639 | 1,341.341 | 929.09 | 894.299 |
| SG&A
| 462.227 | 421.426 | 387.884 | 1,794.411 | 1,167.101 | 1,264.543 | 1,250.764 |
| Other Expenses
| -2,561.2 | 4.458 | 10.027 | -126.142 | 11.531 | 1.215 | 1.777 |
| Operating Expenses
| 2,561.2 | 2,534.954 | 2,430.51 | 1,920.553 | 1,155.57 | 1,263.328 | 1,248.987 |
| Operating Income
| 961 | 1,002.577 | 919.569 | 959.273 | 812.816 | 667.493 | 758.571 |
| Operating Income Ratio
| 0.11 | 0.116 | 0.114 | 0.111 | 0.104 | 0.091 | 0.108 |
| Total Other Income Expenses Net
| -961 | -64.652 | -62.302 | -64.827 | -44.184 | -28.696 | -6.623 |
| Income Before Tax
| 944.246 | 937.925 | 857.267 | 894.446 | 768.632 | 638.797 | 751.948 |
| Income Before Tax Ratio
| 0.108 | 0.109 | 0.106 | 0.103 | 0.098 | 0.087 | 0.107 |
| Income Tax Expense
| 51.628 | 50.114 | 44.738 | 45.33 | 76.63 | 28.144 | 30.711 |
| Net Income
| 892.618 | 887.812 | 812.529 | 849.116 | 692.002 | 610.653 | 721.237 |
| Net Income Ratio
| 0.102 | 0.103 | 0.101 | 0.098 | 0.088 | 0.083 | 0.102 |
| EPS
| 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.7 | 5.55 |
| EPS Diluted
| 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.7 | 5.55 |
| EBITDA
| 1,592.468 | 1,599.169 | 1,458.66 | 1,477.4 | 1,308.143 | 810.535 | 895.099 |
| EBITDA Ratio
| 0.183 | 0.186 | 0.181 | 0.171 | 0.167 | 0.11 | 0.127 |